obesity drug news today glp-1 october 2025 oct 27 Weight loss with GLP-1 medicines does WHO Issues First Guidance on

While no studies show cancer causation, those with a history of cancer should avoid these compounds due to IGF-1s mitogenic properties

[1] Unit calculations do not apply to oral medications

This can lead to mild hyponatremia causing fatigue, weakness, and lightheadedness

Your clinician should talk you through potential next steps, which may be menopause care, joint evaluation, a gastrointestinal workup, physical therapy, or other forms of evidence-backed treatment

Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity

The product is intended for scientific research and development purposes only